[ASLS KOREA 2026 Spring ②] 'Is It Really Safe?' — In the Skin Booster Market, the First Question Physicians Ask Is Changing
This is part two of our on-site coverage from the ASLS KOREA 2026 Spring Congress. The skin booster and drug delivery sections drew as much attention as the EBD halls. Active ingredients are diversifying rapidly — PCL, PDLLA, CaHA, HA, human acellular dermal matrix, exosomes, TCA — and so are the approaches, spanning injectable and topical formats, biostimulators and hydration- and regeneration-focused formulations. Yet across every booth, the first response from clinicians converged around a single question: "Is it really safe?" As ingredient options diversify, the demand for rigorous validation of nodule risk and adverse events is rising in parallel — a shift that was unmistakable on the exhibition floor. We visited skin booster and drug delivery company booths to report firsthand.
#MedicalAestheticNews #ASLSKOREA2026 #ASLS #VAIM #HIGHERCorporation #BAZBIOMEDIC #Curiosis #reH #Humedix #WiQo #DNCAesthetics #HuonsMeditech #Dexlevo #PrimorisInternational
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20027





Comments
Post a Comment